Inscription Capital, LLC
Position in CRL — Charles River Laboratories International, Inc.
CIK 1767868
HOUSTON, TX
Position in CRL
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$767,230
+$174,175 QoQ
Shares Held
3,383
-1.6% QoQ
Ownership
0.007%
of shares outstanding
% of Portfolio
0.09%
of 13F equity value
Holder Rank
#262
of 570 holders
Holding Since
Jun 2025
5 quarters on record
Voting authority
Sole 12%
Shared 0%
None 88%
Common Shares in CRL Over Time
Shares Held
Position Value (USD)
Position in Diagnostics & Research
Healthcare · as of Jun 30, 2026Inscription Capital, LLC holds $6,837,569 across 10 Diagnostics & Research names. CRL ranks #3 (11.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ILMN |
Illumina, Inc.
|
10,731 | $1,886,831 | |
| 2 | IDXX |
Idexx Laboratories Inc /De
|
1,936 | $1,019,187 | |
| 3 | CRL |
Charles River Laboratories International, Inc.
This page
|
3,383 | $767,230 | |
| 4 | IQV |
Iqvia Holdings Inc.
|
3,517 | $679,554 | |
| 5 | A |
Agilent Technologies, Inc.
|
5,110 | $678,761 | |
| 6 | TMO |
Thermo Fisher Scientific Inc.
|
1,231 | $617,174 | |
| 7 | RVTY |
Revvity, Inc.
|
3,785 | $421,119 | |
| 8 | DGX |
Quest Diagnostics Inc
|
1,644 | $348,445 |
All Filings in CRL
Export CSV
5 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $767,230 | 3,383 | Shares | Sole | 2026-08-13 | |
| 2026-03-31 | $593,055 | 3,438 | Shares | Sole | 2026-04-20 | |
| 2025-12-31 | $1,082,976 | 5,429 | Shares | Sole | 2026-01-29 | |
| 2025-09-30 | $922,488 | 5,896 | Shares | Sole | 2025-10-29 | |
| 2025-06-30 | $313,929 | 2,069 | Shares | Sole | 2025-08-12 | |
| No filing history on record for this holder in this stock. | ||||||